Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes

Title
Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes
Authors
Keywords
-
Journal
JCI Insight
Volume 5, Issue 13, Pages -
Publisher
American Society for Clinical Investigation
Online
2020-07-08
DOI
10.1172/jci.insight.137230

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now